The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer.
Saved in:
| Title: | The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer. |
|---|---|
| Authors: | López-Plana A; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain., Fernández-Nogueira P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Muñoz-Guardiola P; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Solé-Sánchez S; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Megías-Roda E; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Pérez-Montoyo H; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Jauregui P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Yeste-Velasco M; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Gómez-Ferreria M; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Erazo T; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Ametller E; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Recalde-Percaz L; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain., Moragas-Garcia N; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Noguera-Castells A; Department of Medicine, University of Barcelona, Barcelona, Spain., Mancino M; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain., Morán T; Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Institut Germans Trias i Pujol, Badalona-Applied Research Group in Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Nadal E; Department of Medical Oncology, Thoracic Oncology Multidisciplinary Unit, Catalan Institute of Oncology, Barcelona, Spain., Alfón J; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Domènech C; Ability Pharmaceuticals, SL, Cerdanyola Del Vallès, Barcelona, Spain., Gascon P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), University of Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Department of Medical Oncology, Hospital Clínic, Barcelona, Spain., Lizcano JM; Protein Kinases and Signal Transduction Laboratory, Institut de Neurociències and Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain., Fuster G; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Biochemistry and Molecular Biomedicine Department, School of Biology, University of Barcelona, Barcelona, Spain.; Department of Biochemistry & Physiology, School of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.; Department of Biosciences, Faculty of Sciences and Technology, University of Vic, Vic, Spain., Bragado P; Molecular and Translational Oncology Group, Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain. |
| Source: | International journal of cancer [Int J Cancer] 2020 Aug 15; Vol. 147 (4), pp. 1163-1179. Date of Electronic Publication: 2020 Feb 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.32865 |
